- likes
- 146
- comments
- 6
Post
One of our favourite moments of 2025 was seeing Rebecca Paul and Max Jaderberg sit down with Bloomberg’s Tom Mackenzie to share how Isomorphic Labs is building a generalisable drug design engine that can tackle any target, in any disease area. Bloomberg’s interview also features our Founder and CEO Demis Hassabis and Mihaela van der Schaar from the University of Cambridge’s Centre for AI in Medicine. Watch to see how we’re working to solve all disease with the help of cutting-edge AI. https://bit.ly/47A7SSl